BRUSSELS, Jan 29 (Reuters) - The European Commission gave
approval on Friday for the use of the COVID-19 vaccine developed
by AstraZeneca, the final step to allowing Europe to use it
across the continent.
"I expect the company to deliver the 400 million doses as
agreed," Ursula von der Leyen, the president of the European
Commission wrote on Twitter.
(Reporting by Marine Strauss @StraussMarine)